NCT03083314View on ClinicalTrials.gov

Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment

NACompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

June 12, 2014

Primary Completion Date

November 15, 2018

Study Completion Date

December 4, 2020

Conditions

Breast Cancer

Interventions

PROCEDURE

SELECTIVE AXILLARY LYMPH NODE DISSECTION (SAD)

PROCEDURE

COMPLETE AXILLARY DISSECTION (ALND)

Trial Locations (1)

20133

Massimiliano Gennaro, Milan

All Listed Sponsors

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT03083314 - Selective Axillary Lymph Node Dissection Vs Complete Axillary Dissection: A Randomised Clinical Trial to Assess the Prevention of Lymphedema in Breast Cancer Treatment | Biotech Hunter | Biotech Hunter